Pharmacotherapy

Individuals with narcolepsy were significantly more likely to have sleep, mood and pain disorders compared with matched controls, indicating where treatment may best target common comorbidities, according to new research from Sleep Advances.

The 19th annual Cardiometabolic Health Congress will be held at the Boston Park Plaza and will feature the latest science in the areas of cardio-renal, obesity, diabetes and dyslipidemia, atherosclerosis, thrombosis and more.

A recently proposed U.S. Senate bill aims to crack down on social media influencers and others online who make misleading comments about pharmaceutical drugs.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Baruch D. Kuppermann, MD, PhD, comments on the decision of the European Medicines Agency to reject the appeal for the approval of pegcetacoplan.

The Healio news team won an APEX Grand Award for its Treating Obesity resource center, a collection of the latest news and perspectives on medications for obesity.

Most patients who qualified for an SGLT2 inhibitor were not prescribed one, according to an analysis of more than 3 million U.S. adults.

In an analysis of more than 3 million U.S. adults, most patients with a class 1a recommendation for SGLT2 inhibitors were not prescribed them, researchers reported in the Journal of the American College of Cardiology.

Hyperkalemia may be considered a common occurrence in patients with chronic kidney disease, particularly in those with heart failure or diabetes, published data show.

Shortly after graduating pharmacy school, Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, was diagnosed with type 1 diabetes. Learning how to manage the disease while also going through pharmacy training was overwhelming, he said.

Continuous glucose monitors have the potential to alleviate burdens, improve neonatal outcomes and predict disease progression for pregnant women with type 1, type 2 or gestational diabetes, according to two diabetes experts.